Review Article
Alternative Methods to Treat Nausea and Vomiting from Cancer Chemotherapy
Table 1
The effect of medicinal therapy on the intensity of nausea and vomiting in cancer patients under chemotherapy.
| Study | Year | Sample size | Design/population | Method | Outcome |
|
Ekangaki and Chung [5] | 2005 | 450 | Cancer patients under chemotherapy in two various age-gender groups | Case-control | The application of histamines, phenothiazines, butyrophenones, and anticholinergics to cope with CINV in chemotherapy brings about side effects | Sirin and Flynn [6] | 2013 | 52 | Cancer patients under chemotherapy in two various age-gender groups | Case-control | CINV was reduced by about %13.8 in the group receiving dimenhydrinate as compared to placebo | Pierce and Lin [7] | 2013 | 85 | Over 30-year-old men with prostate cancer under chemotherapy | Case-control | Prescribing dimenhydrinate for men with prostate cancer under chemotherapy has reduced their CINV as compared to control group | Sheanakul et al. [8] | 2011 | 30 | Below 60-year-old cancer patients under chemotherapy in two gender groups | Case-control | The continuous injection of midazolam has reduced pain and CINV in test group as compared to control group | Apfel et al. [9] | 2012 | 23 | 15–50 years of age cancer patients under chemotherapy in two gender groups | Case-control | Cinnarizine controls and reduces CINV in cancer patients under chemotherapy as compared to placebo group through hindering histaminic H1 receptor | Rosenthal et al. [10] | 2010 | 64 | Over 12-year-old cancer patients under chemotherapy in two various gender groups | Clinical trial | Metoclopramide reduces CINV in cancer patients under chemotherapy through enhancing the activity threshold of CTZ chemical receptors | Denehy et al. [11] | 2011 | 85 | Cancer patients under chemotherapy in two various age-gender groups | Case-control | CINV is less in cancer patients under chemotherapy receiving metoclopramide as compared to the group receiving placebo |
|
|